← Open Payments lookup

AMBER REED: Open Payments

NPI 1093300436 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,098 in 44 payments from 13 companies in 2025. Trend: 2023 $126 · 2024 $1,117 · 2025 $1,098

Food & beverage: $1,050Consulting: $48
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$316
GENZYME CORPORATION8$150
Takeda Pharmaceuticals U.S.A., Inc.10$139
Pharming Healthcare, Inc.2$124
Novartis Pharmaceuticals Corporation4$95
Blueprint Medicines Corporation2$49
ADMA BioManufacturing LLC3$48
BioCryst US Sales Co., LLC2$38
Regeneron Healthcare Solutions, Inc.2$36
Genentech USA, Inc.1$32

Products named: DUPIXENT, AIRSUPRA, TEZSPIRE, RUCONEST, CUVITRU, Rhapsido, TAKHZYRO, AYVAKIT.

Industry payments across AZ — which companies pay providers there.